Form 4 for NVCR NovoCure Ltd
Accepted 2022-09-07 00:00:00 ET · period of report 2022-09-06 · accession 0001645113-22-000079 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-07 | 2022-09-06 | NVCR | Leonard Frank X | Chief Development Off | S - Sale | $78.57 | -1,384 | 86.0K | -2% | -$108.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-09-06 | S | D | 1,384 | $78.57 | 86,013 | D | — | — | (F1) Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Leonard. |